Cold agglutinin disease secondary to severe SARS-CoV-2 treated with eculizumab

Impaired immune response with uncontrolled inflammation and various immunological disorders have been reported during SARS-CoV-2 infection. Here, we report a case of cold agglutinin disease occurring during a severe coronavirus disease 2019 (COVID-19) in a French intensive care unit. A patient was p...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawudi, Yachar, Federici, Laura, Debus, Jérôme, Zucman, Noémie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Case Reports: Adverse drug reactions and complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058691/
https://www.ncbi.nlm.nih.gov/pubmed/35487646
http://dx.doi.org/10.1136/bcr-2021-242937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058691/
https://www.ncbi.nlm.nih.gov/pubmed/35487646
http://dx.doi.org/10.1136/bcr-2021-242937

Ejemplares similares